-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Application of biomarkers in oncology clinical trials
Naveen Dakappagari, Hua Gong, Reinhold Pollner, Amara Siva, Shabnam Tangri & Jelveh Lameh
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections
Konstantinos Z Vardakas & Matthew E Falagas
Review: Clinical Trail Outcomes: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Interview with Professor Morris Brown
Morris Brown
Interview: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
HCV protease inhibitors: using the evidence to guide clinical practice
Derek Yu, Jordan J Feld
Review: Clinical Trail Outcomes: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of diabetic macular edema: latest clinical evidence
Shani Golan, Anat Lowenstein
Review: Clinical Trail Outcomes: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Advances in the development and application of biological therapies for rheumatoid arthritis: review of the latest clinical evidence
Sarah C Horton, Maya H Buch
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation
-
Tocilizumab for rheumatoid arthritis: results of the Phase III clinical trial program
Javier Rueda, Miguel A Gonzlez-Gay, Ricardo Blanco
Review Article: Clinical Investigation